Methylcellulose culture of human granulocytic progenitor cells (CFC *): results of bone marrow and blood cultures for normal subjects. 1979

C Parmentier, and N Morardet, and G Tchernia, and J P Droz, and E Subtil, and P Gardet, and P Charbord

Normal values for the colony-forming ability of granulocytic progenitor cells (CFC) were established for 26 samples of normal bone marrow and 8 samples of normal blood cultured in methylcellulose. The concentration of CFC in the marrow was measured classically as the number of CFC per 10(5) nucleated marrow cells plated and, in addition, as the number of CFC per 10(5) precursors (myeloblasts, promyelocytes, and myelocytes) and per 10(5) metamyelocytes. A value approximating the total number of marrow CFC was calculated by using the number of CFC per 10(5) metamyelocytes. The normal value for circulating CFC were determined as number per ml of blood, per kg of body weight, per 10(5) circulating lymphocytes, and per 10(5) circulating granulocytes. The value of these different modes of expression are discussed. Although the values reported are not directly applicable from one laboratory to the next, they may constitute a useful reference point. Furthermore, they show that the statistical variation in the results is sufficiently small to permit the comparison of values found for pathologic samples with those determined for normal samples.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008747 Methylcellulose Methylester of cellulose. Methylcellulose is used as an emulsifying and suspending agent in cosmetics, pharmaceutics and the chemical industry. It is used therapeutically as a bulk laxative. BFL,Celevac,Cellothyl,Cellulone,Citrucel,Cologel,Dacryolarmes,Methocel,Methyl Cellulose,Muciplasma,Cellulose, Methyl
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001773 Blood Cells The cells found in the body fluid circulating throughout the CARDIOVASCULAR SYSTEM. Blood Corpuscles,Blood Cell,Blood Corpuscle,Cell, Blood,Cells, Blood,Corpuscle, Blood,Corpuscles, Blood
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D006098 Granulocytes Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS. Granulocyte

Related Publications

C Parmentier, and N Morardet, and G Tchernia, and J P Droz, and E Subtil, and P Gardet, and P Charbord
January 1977, Nouvelle revue francaise d'hematologie; blood cells,
C Parmentier, and N Morardet, and G Tchernia, and J P Droz, and E Subtil, and P Gardet, and P Charbord
January 1988, Haematologia,
C Parmentier, and N Morardet, and G Tchernia, and J P Droz, and E Subtil, and P Gardet, and P Charbord
February 1980, British journal of haematology,
C Parmentier, and N Morardet, and G Tchernia, and J P Droz, and E Subtil, and P Gardet, and P Charbord
January 1990, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
C Parmentier, and N Morardet, and G Tchernia, and J P Droz, and E Subtil, and P Gardet, and P Charbord
January 1979, Nouvelle revue francaise d'hematologie,
C Parmentier, and N Morardet, and G Tchernia, and J P Droz, and E Subtil, and P Gardet, and P Charbord
January 1980, Cell and tissue kinetics,
C Parmentier, and N Morardet, and G Tchernia, and J P Droz, and E Subtil, and P Gardet, and P Charbord
October 1979, Haematologica,
C Parmentier, and N Morardet, and G Tchernia, and J P Droz, and E Subtil, and P Gardet, and P Charbord
January 1981, Blood,
C Parmentier, and N Morardet, and G Tchernia, and J P Droz, and E Subtil, and P Gardet, and P Charbord
October 1982, Bollettino della Societa italiana di biologia sperimentale,
C Parmentier, and N Morardet, and G Tchernia, and J P Droz, and E Subtil, and P Gardet, and P Charbord
April 1994, Biotechnology and bioengineering,
Copied contents to your clipboard!